Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting Report

Evaluation of the Anti Glypican 1 Chimeric Antibody Miltuximab for Delivery of Radioisotopes in Cancer Treatment

Jay Tinklepaugh, Thomas Jeitner, James Kelly, Clarence Williams Jr., Anastasia Nikolopoulou, Shashikanth Ponnala, Justin Wilson, Douglas Campbell, Brad Walsh and John Babich
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1074;
Jay Tinklepaugh
1Radiology Weill Med Col/Cornell UN New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Jeitner
1Radiology Weill Med Col/Cornell UN New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Kelly
2Radiology Weill Cornell Medicine New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clarence Williams Jr.
1Radiology Weill Med Col/Cornell UN New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anastasia Nikolopoulou
2Radiology Weill Cornell Medicine New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shashikanth Ponnala
2Radiology Weill Cornell Medicine New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justin Wilson
3Cornell University Ithaca NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas Campbell
4Minomic International Ltd. Sydney Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brad Walsh
4Minomic International Ltd. Sydney Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Babich
5Weill Cornell Medical College New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 61 no. supplement 1 1074

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 15, 2020.

Copyright & Usage 
© 2020

Author Information

  1. Jay Tinklepaugh1,
  2. Thomas Jeitner1,
  3. James Kelly2,
  4. Clarence Williams Jr.1,
  5. Anastasia Nikolopoulou2,
  6. Shashikanth Ponnala2,
  7. Justin Wilson3,
  8. Douglas Campbell4,
  9. Brad Walsh4 and
  10. John Babich5
  1. 1Radiology Weill Med Col/Cornell UN New York NY United States
  2. 2Radiology Weill Cornell Medicine New York NY United States
  3. 3Cornell University Ithaca NY United States
  4. 4Minomic International Ltd. Sydney Australia
  5. 5Weill Cornell Medical College New York NY United States

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2020 to April 2025

AbstractFullPdf
May 20202200
Jun 20204500
Jul 20203100
Aug 20201700
Sep 20202800
Oct 20201000
Nov 20202300
Dec 20201400
Jan 20211800
Feb 20211700
Mar 20212200
Apr 20211400
May 20213300
Jun 20211900
Jul 20213500
Aug 202113600
Sep 2021800
Oct 2021600
Nov 20214100
Dec 20211200
Jan 20221200
Feb 20221800
Mar 2022500
Apr 2022800
May 2022200
Jun 20221000
Jul 2022300
Aug 20221500
Sep 20221200
Oct 2022100
Nov 2022300
Dec 2022500
Jan 20231100
Feb 20231100
Mar 2023600
Apr 2023500
May 20231000
Jun 2023700
Jul 2023400
Aug 20231300
Sep 20231200
Oct 2023500
Nov 20231100
Dec 20231200
Jan 20242000
Feb 20241900
Mar 20241000
Apr 20241200
May 20241000
Jun 2024700
Jul 2024800
Aug 20241200
Sep 20241800
Oct 20241300
Nov 2024600
Dec 2024300
Jan 2025800
Feb 20251400
Mar 2025700
Apr 20251500
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of the Anti Glypican 1 Chimeric Antibody Miltuximab for Delivery of Radioisotopes in Cancer Treatment
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Evaluation of the Anti Glypican 1 Chimeric Antibody Miltuximab for Delivery of Radioisotopes in Cancer Treatment
Jay Tinklepaugh, Thomas Jeitner, James Kelly, Clarence Williams Jr., Anastasia Nikolopoulou, Shashikanth Ponnala, Justin Wilson, Douglas Campbell, Brad Walsh, John Babich
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1074;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evaluation of the Anti Glypican 1 Chimeric Antibody Miltuximab for Delivery of Radioisotopes in Cancer Treatment
Jay Tinklepaugh, Thomas Jeitner, James Kelly, Clarence Williams Jr., Anastasia Nikolopoulou, Shashikanth Ponnala, Justin Wilson, Douglas Campbell, Brad Walsh, John Babich
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1074;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Rest Dose Spillover Correction of Stress Blood Flow Measurements in Digital Rb-82 Myocardial Perfusion PET/CT Imaging
  • Radiolabeled hyaluronic acid (HA) fragments for lymphatic imaging
  • Simplifying and Confirming Ketosis: A Quality Improvement Initiative in Cardiac Sarcoid Assessment
Show more

Preclinical Probes for Oncology (Poster Session)

  • An alkyne-conjugated quinoline for facile solid-phase construction of FAP-targeting ligands: synthesis, radiolabeling and in vivo evaluation
  • Synthesis and in vivo evaluation of F-18-labeled isoxazole analog for imaging of sigma-2 receptor status
  • Preclinical results of novel GRPR-targeted antagonists with modified binding sequences
Show more Preclinical Probes for Oncology (Poster Session)

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire